COLL Collegium Pharmaceutical, Inc

$33.51 -0.56%

Healthcare · Pharmaceutical Preparations

Collegium Pharmaceutical, Inc (COLL) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.1 billion. Shares last traded at $33.51, 36.2% below their 52-week high. Over the past year the stock is up 14.0%. COLL trades at a price-to-earnings ratio of 17.25, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 8.1%, above the peer median of -0.1%. Revenue grew 23.6% year over year.

Market Cap

$1.1B

Shares Out

32.4M

EPS (TTM)

$1.73

P/E Ratio

19.37

P/S Ratio

1.39

P/B Ratio

3.48

Dividend / Share

—

Dividend Yield

—

52-Week High

$52.55

52-Week Low

$29.11

Volume

13,845

Avg Vol (3m)

24,573.841

Performance

-2.27%

-0.39%

-7.67%

-31.22%

YTD

-26.38%

+14.02%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

47.57

SMA (50)

$34.14

SMA (200)

$39.31

Price vs SMA50

-1.85%

Price vs SMA200

-14.76%

ATR (14)

$1.55

Financials

Revenue

$781M

Net Income

$63M

Gross Margin

59.3%

Operating Margin

23.0%

Net Margin

8.1%

Return on Equity

20.2%

Return on Assets

3.8%

Current Ratio

1.71

Debt / Equity

0.04

Revenue Growth (YoY)

+23.6%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.40	2026-05-07
FY 2025	$1.73	2026-02-26
FY 2025	$0.84	2026-02-26
FY 2025	$0.34	2026-02-26
Q1 2026	$0.07	2026-05-07
FY 2025	$1.86	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

COLL vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

17.25 / 16.82 med

+3% premium

P/S vs peers

1.39 / 3.54 med

-61% discount

Net margin vs peers

8.1% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.